Allergy/Asthma News

The FDA approved omalizumab so people with immunoglobulin E-mediated food allergies can build tolerance to allergens, but experts warned that the biologic is not a cure.

The results of the second annual national primary care scorecard suggest the field is facing major problems — poor funding and a diminishing workforce, among them — but increased attention on the issues may offer hope, according to experts.

WASHINGTON — Single maintenance and reliever therapy was not commonly initiated by primary care providers, although PCPs supported efforts to improve adoption, a study showed.

WASHINGTON — A digital self-assessment demonstrated effectiveness at identifying low-risk patients with penicillin or sulfa allergies, results of a study here showed.

WASHINGTON — Patients with multiple food allergies experienced a protective effect against allergic reactions with omalizumab, according to an abstract presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

WASHINGTON — ChatGPT provided decent quality information on current anaphylaxis guidelines, but also had errors in more than half of its sources, research here showed.

WASHINGTON — Primary care providers spent significantly more time with electronic health record documentation vs. allergy and immunology providers — both before and after the COVID-19 pandemic — research showed.

WASHINGTON — Early onset of eczema was associated with a greater number of food allergies in children, and the condition also increased the risk for asthma, according to research presented here.

WASHINGTON — Food allergies, particularly when combined with asthma, were associated with higher odds of mental health disorders and physical diseases in addition to higher health care use, researchers found.

The FDA has approved Xolair for the reduction of allergic reactions in children and adults with immunoglobulin E-mediated food allergy, according to a press release from Roche.